Fig. 5From: Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectivesPresence of Fr-221 and Bi-213 in different chemical forms after labelling of [225Ac]Ac-PSMA-I&TBack to article page